Evidence map›Paper›PMID 32966707›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2021

No dose effect observed with chronic fluticasone propionate on growth velocity in children.

Laurie A Lee, Søren Pedersen, Steven J Pascoe, Stanley J Szefler, Warren Lenney

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. No dose effect observed with chronic fluticasone propionate on growth velocity in children.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Laurie A LeeRespiratory Clinical Development, GlaxoSmithKline, Collegeville, PA, USA.ORCID 0000-0003-2036-7910
Søren PedersenDepartment of Pediatrics, Center Lillebaelt, Fredericia and Kolding Hospital, Odense, Denmark.
Steven J PascoeRespiratory Clinical Development, GlaxoSmithKline, Collegeville, PA, USA.
Stanley J SzeflerDepartment of Pediatrics, Breathing Institute, Pediatric Pulmonary Section, Children's Hospital Colorado, CO, USA.ORCID 0000-0002-6911-3199
Warren LenneyRespiratory Child Health, Keele University, Staffordshire, UK.
GlaxoSmithKline (United States) · USChildren's Hospital Colorado · USKeele University · GBKolding Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Asthmatic AgentsAsthmaAdministration, InhalationAndrostadienesChildDouble-Blind MethodFluticasoneHumansAndrostadienesAnti-Asthmatic AgentsFluticasone

Identifiers

PMID32966707
PMCPMC7894339
OpenAlexW3088038924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.